The Global Pharma Lobby around the world are making multiple announcements for development of their vaccines and have been running into a rat race of manufacturing the vaccine as well as its Human Trials, But the facts behind this rat race of making fool of the common man and digging out the money from the common man’s pocket in the name of Vaccine and saving their life from this Global Pandemic is far more different from what is shown. Before we dig deep into the same, let us first understand the basics of Immunity and types of Immunity.
What is Immunity
Immunity refers to the body’s ability to prevent the invasion of pathogens. Pathogens are foreign disease-causing substances, such as bacteria and viruses, and people are exposed to them every day. Antigens are attached to the surface of pathogens and stimulate an immune response in the body. An immune response is the body’s defense system to fight against antigens and protect the body.
What is Active Immunity
Active immunization is the induction of immunity after exposure to an antigen. Antibodies are created by the recipient and may be stored permanently.
Active immunization can occur naturally when a microbe or other antigen is received by a person who has not yet come into contact with the microbe and has no pre-made antibodies for defense. The immune system will eventually create antibodies for the microbe, but this is a slow process and, if the microbe is deadly, there may not be enough time for the antibodies to be used.
What is a Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future. Vaccines can be prophylactic (to prevent or ameliorate the effects of a future infection by a natural or “wild” pathogen), or therapeutic (to fight a disease that has already occurred, such as cancer).
Now let us simply calculate 2+2.
The so-called vaccines claimed by pharma lobby around the world would provide you with the active immunity against the disease, but as per one report of WHO and several mainstream media houses around the world, it has been observed that there are several cases where a person who has been infected by Coronavirus Covid-19 Diseases once has been re-infected again even after getting treated and getting healthy.
If we take this point into the consideration then it actually means that even if the human body has been infected by the coronavirus and then developed the antibodies against it and activated the defence mechanism of the human body called as Immunity, there is no guarantee that the person will not get infected again.
In other words, a person can be infected with coronavirus COVID-19 disease again and again no matter how strong his immunity has been developed.
If this point is taken into the consideration, even if the global pharma lobby is successful in making the vaccine, it will not be as successful in preventing the COVID-19 disease as claimed by the large pharma companies around the world.
Now the question that arises is why pharma companies are making such big claims?
The answer is money.
People have become so much annoyed, frustrated, irritated with the loss of life, money, job, health & lockdown and its overall impact on the economy that they are now ready to buy anything and everything in the name of safety.
Why are pharma companies allowed to make such big claims?
Again the answer is money, there are heavy taxes around the world on vaccines and medicines.
A large part of the revenue that Global Pharma companies make through sales of medicine and vaccine also goes in the taxes to the government. Apart than this many giant pharma companies also pay a bribe to the global leaders in the ruling party to prevent any sort of investigations against them which is finally used in the elections.
Let us take a small scenario of a country like India.
Firstly government promoted sanitizers and mask with a lot of enthusiasm, later when people got habitual of sanitizers, pharma companies raised and almost doubled and tripled the price of sanitizers in the market, lot of fake sanitizers also arrived in the market to fulfil the demand and need.
Finally, there was 18% tax implied on the sanitizer by the government who earlier bombarded the common man for the use of sanitizers and told people to be self reliant.
Whether its the government or the pharma lobby, the main motto and motivation is to earn money and not to save human life, the leaders and politicians around the world are more interested in busy in making their governments rather saving the human life.
Mostly these big pharma companies have a huge share in funding the elections around the world, or the Global Political Leaders or their relatives are shareholders of these pharma companies or the relatives and or immediate family members of the political leaders are the directors of such companies.
In India recently one company known as Patanjali Ayurved released a drug named Coronil without any approval of ICMR and claimed in Big Sponsored News & Ads that it treats Coronavirus, several media houses kept running news for days in favour of coronil but later due to public outrage they retracted from their statement and claims and released a statement that the coronil just boost their immunity which will help people fight diseases like coronavirus.
Patanjli owner Balkrishna has been booked and arrested by CBI multiple times in money laundering & fake documents and passport case, Baba Ramdev who is the brand ambassador of Patanjli is a yoga guru and a close aide of BJP & Modi which is a current ruling party in India and has been funding the elections for them and promoting BJP during his yoga sessions as well as influencing his followers to vote for BJP.
Patanjli started as a yoga center in 2006 and within the span of 14 years, left behind major pharma companies of India and declared a total revenue of 9500 crores in such a short span of time.
They have also announced to be Rs 40,000-crore company in 2020-21, aims to be largest FMCG firm. So now we all can understand, how are they able to make such huge claims.
Not just this, there are many large media houses beloning to local, national and global leaders who supports such claims by these pharma companies together with political leaders.
Zee News, one such TV channel whose founder Subhash Chandra Goenka is a standing MP from BJP openly supports the giant pharma lobby and present such news in their prime time shows, in return such media houses gets high paying ads from Pharma companies, political leaders, government ads which runs such media houses.
Zee News chief editor Sudhir Chaudhary has also been arrested and sent to Tihar Jail for an extortion and blackmailing case for an amount of 100 crores.
As you can see, the entire group is filled with people who are history sheeters, criminals and have a long-standing crime record and a good hold in the crime world.
In Short, this is a whole massive lobby of Pharma Companies, Political Leaders & Their Supportive Media houses which is playing this large circus in the name of Vaccine game which would turn out to be a game of not just billions but trillions and in the end, only the common man will pay the price from his pocket.
As of now there are a total of 41 vaccines getting developed around the world.
Candidate | Sponsor | Trial Phase | Institution | Funding | |
---|---|---|---|---|---|
Bacillus Calmette-Guerin (BCG) live-attenuated vaccine | University of Melbourne and Murdoch Children’s Research Institute; Radboud University Medical Center; Faustman Lab at Massachusetts General Hospital | Phase 2/3 | University of Melbourne and Murdoch Children’s Research Institute; Radboud University Medical Center; Faustman Lab at Massachusetts General Hospital | Murdoch Children’s Research Institute; UMC Utrecht | |
AZD1222 | The University of Oxford; AstraZeneca; IQVIA | Phase 2/3 | The University of Oxford, the Jenner Institute | Operation Warp Speed; UK Ministry of Health; The University of Oxford; BARDA | |
mRNA-1273 | Moderna | Phase 2 | Kaiser Permanente Washington Health Research Institute | Operation Ward Speed; NIAID, BARDA ($483 million) | |
BNT162 | Pfizer, BioNTech | Phase 1/2 | Multiple study sites in Europe and North America | Pfizer; BioNTech | |
Inactivated vaccine | Wuhan Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) | Phase 1/2 | Henan Provincial Center for Disease Control and Prevention | Ministry of Science and Technology, China | |
BBIBP-CorV | Beijing Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) | Phase 1/2 | Henan Provincial Center for Disease Control and Prevention | Ministry of Science and Technology, China | |
CoronaVac | Sinovac | Phase 1/2 | Sinovac Research and Development Co., Ltd. | Sinovac Research and Development Co., Ltd. | |
GX-19 | Genexine | Phase 1/2 | GenexineGenexine | ||
Gam-COVID-Vac | Gamaleya Research Institute, Acellena Contract Drug Research and Development | Phase 1/2 | Various | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | |
Ad5-nCoV | CanSino Biologics | Phase 1 | Tongji Hospital; Wuhan, China | CanSino Biologics | |
INO-4800 | Inovio Pharmaceuticals | Phase 1 | Center for Pharmaceutical Research, Kansas City. Mo.; University of Pennsylvania, Philadelphia | Inovio Pharmaceuticals | |
mRNA-based vaccine | CureVac | Phase 1 | CureVac | CureVac; German federal government | |
SCB-2019 | GlaxoSmithKline, Sanofi, Clover Biopharmaceuticals, Dynavax and Xiamen Innovax | Phase 1 | Linear Clinical Research (Australia) | CEPI | |
Adjuvant recombinant vaccine candidate | Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences | Phase 2 | |||
COVAX-19 | Vaxine Pty Ltd. | Phase 1 | Royal Adelaide Hospital | NIAID | |
bacTRL-Spike | Symvivo | Pre-clinical | Symvivo Corporation | Symvivo Corporation | |
PittCoVacc | UPMC/University of Pittsburgh School of Medicine | Pre-clinical | University of Pittsburgh | CEPI | |
Measles vector vaccine | University of Pittsburgh’s Center for Vaccine Research | Pre-clinical | University of Pittsburgh; Themis Biosciences; Institut Pasteur | Merck | |
NVX-CoV2373 | Novavax | Pre-clinical | Novavax | Novavax, CEPI, Department of Defense ($60 million) | |
Ii-Key peptide COVID-19 vaccine | Generex Biotechnology | Pre-clinical | Generex | Generex | |
Recombinant vaccine | Vaxart | Pre-clinical | Vaxart | no information | |
Self-amplifying RNA vaccine | Imperial College London | Pre-clinical | Imperial College London | UK Secretary of State for Health; UK Secretary of State for Business, Energy and Industrial Strategy | |
Plant-based adjutant COVID-19 vaccine candidate | Medicago; GSK; Dynavax | Phase 1 | Medicago | Medicago | |
DNA-based vaccine | Takis Biotech | Pre-clinical | Takis Biotech | Takis Biotech | |
Ad26.COV2-S | Johnson & Johnson | Pre-clinical | Johnson & Johnson | Operation Warp Speed; Johnson & Johnson; BARDA | |
AdCOVID | Altimmune | Pre-clinical | University of Alabama at Birmingham | Altimmune | |
T-COVIDTM | Altimmune | Pre-clinical | Altimmune | ||
Protein subunit vaccine | University of Saskatchewan Vaccine and Infectious Disease Organization-International Vaccine Centre | Pre-clinical | University of Saskatchewan Vaccine and Infectious Disease Organization-International Vaccine Centre | no information | |
LUNAR-COV19 | Arcturus Therapeutics and Duke-NUS Medical School | Pre-clinical | Duke-NUS Medical School, Singapore | Arcturus | |
Recombinant vesicular stomatitis virus (rVSV) vaccine | Merck; IAVI | Pre-clinical | BARDA | ||
Adenovirus-based vaccine | ImmunityBio; NantKwest | Pre-clinical | |||
Molecular clamp vaccine | CSL; The University of Queensland | Phase 1 | CEPI; CSL | ||
AAVCOVID | Massachusetts Eye and Ear; Massachusetts General Hospital; University of Pennsylvania | Pre-clinical | Wyc Grousbeck; Emilia Fazzalari | ||
Recombinant vaccine | Sanofi, Translate Bio | Pre-clinical | BARDA | ||
Covaxin | Bharat Biotech; National Institute of Virology | Phase 1 | |||
mRNA lipid nanoparticle (mRNA-LNP) vaccine | CanSino Biologics, Precision NanoSystems | Early research | |||
Adenovirus-based vaccine | ReiThera; Leukocare; Univercells | Early research | |||
gp96-based vaccine | Heat Biologics | Early research | University of Miami Miller School of Medicine | ||
HaloVax | Voltron Therapeutics, Inc.; Hoth Therapeutics, Inc. | Pre-clinical | MGH Vaccine and Immunotherapy Center | ||
ZyCoV-D | Zydus Cadila | Phase 1/2 | Zydus Cadila | ||
mRNA-based vaccine | Chulalongkorn University’s Center of Excellence in Vaccine Research and Development | Pre-clinical |